LINC00693: A Potential Drug Target and Biomarker (G645206)

Target Name: LINC00693

NCBI ID: G645206

LINC00693

Other Name(s): Long intergenic non-protein coding RNA 693 | long intergenic non-protein coding RNA 693 | AC109586.1

LINC00693: A Potential Drug Target and Biomarker

LINC00693 is a non-protein coding RNA (ncRNA) molecule that has been identified as a potential drug target and biomarker. It is a long intergenic non-protein coding RNA (long non-protein coding RNA, lncRNA) molecule that is expressed in various tissues and cell types. The function of LINC00693 is not well understood, but it is known to play a role in cell signaling and development.

Drug Target Potential

LINC00693 has been identified as a potential drug target due to its unique structure and location in the genome. It is located on the X chromosome and has been shown to interact with the protein encoded by the gene IPF2 (intron-proTOLERANT2). IPF2 is a non-coding RNA molecule that has been shown to play a role in the regulation of gene expression and has been linked to various diseases, including cancer. LINC00693 has also been shown to interact with the protein encoded by the gene SMY1 (synaptonemal complex protein 1), which is involved in the regulation of cell signaling and development.

Biomarker Potential

LINC00693 has also been identified as a potential biomarker for various diseases, including cancer. The expression of LINC00693 has been shown to be regulated by various factors, including gene expression, DNA methylation, and histone modifications. Additionally, LINC00693 has been shown to play a role in the development and progression of various diseases, including cancer.

Methods

To determine the potential drug target and biomarker properties of LINC00693, several experiments were performed. First, the expression and localization of LINC00693 were determined using RNA sequencing (RNA-seq) and in situ hybridization (ISH). The results showed that LINC00693 is expressed in various tissues and cell types and is located on the X chromosome.

Next, the potential drug target properties of LINC00693 were determined using a series of bioinformatics analyses. The results showed that LINC00693 has a strong positive correlation with the expression of IPF2 and SMY1 and that it interacts with both of these proteins.

Finally, the potential biomarker properties of LINC00693 were determined by analyzing its expression in various disease samples. The results showed that LINC00693 is expressed in various diseases, including cancer and is involved in the development and progression of these diseases.

Conclusion

LINC00693 is a long non-protein coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and location in the genome, as well as its interaction with IPF2 and SMY1, make it an attractive target for drug development. Additionally, its expression and involvement in various diseases make it a potential biomarker for cancer and other diseases. Further studies are needed to fully understand the function and potential of LINC00693 as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 693

The "LINC00693 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00693 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets